Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement (REHAB-TAVR)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02805309 |
|
Recruitment Status :
Completed
First Posted : June 20, 2016
Results First Posted : July 21, 2021
Last Update Posted : July 21, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Aortic Valve Stenosis | Behavioral: Exercise Behavioral: Cognitive behavioral interventions Behavioral: Attention control education program | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 64 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement: A Pilot Study |
| Actual Study Start Date : | August 1, 2017 |
| Actual Primary Completion Date : | May 6, 2020 |
| Actual Study Completion Date : | May 6, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Exercise & Cognitive Behavioral Int.
A physical therapist will make home visits, beginning within 1 week of discharge, to deliver an individualized exercise program and cognitive behavioral interventions.
|
Behavioral: Exercise
Exercises will target balance, flexibility, strength, and endurance (source: https://go4life.nia.nih.gov/). Home visits will take place twice a week for week 1 and 2; once a week for week 3 and 4; every other week for week for week 5 through week 8. Participants are instructed to do prescribed exercises for 30 minutes daily. The duration of this intervention is about 40 mins. Behavioral: Cognitive behavioral interventions The following cognitive-behavioral strategies will be employed: 1) enhance positive beliefs about exercise through discussion of benefits of exercise; 2) discussion of barriers to exercise; 3) individualized goal setting and self-monitoring progress using exercise calendar; 4) develop a detailed exercise plan on how, what, when, and where to conduct exercise; 5) $10 rewards for exercising ≥30 mins per day for ≥5 of 7 days. The duration of this intervention is about 20 mins. |
|
Experimental: Exercise Alone
A physical therapist will make home visits, beginning within 1 week of discharge, to deliver an individualized exercise program, without cognitive behavioral interventions.
|
Behavioral: Exercise
Exercises will target balance, flexibility, strength, and endurance (source: https://go4life.nia.nih.gov/). Home visits will take place twice a week for week 1 and 2; once a week for week 3 and 4; every other week for week for week 5 through week 8. Participants are instructed to do prescribed exercises for 30 minutes daily. The duration of this intervention is about 40 mins. |
|
Active Comparator: Attention Control Education Program
Participants will receive telephone-based education sessions from a study health professional.
|
Behavioral: Attention control education program
A health care professional will call the participant weekly for a period of 8 weeks to teach general tips about exercise and diet (source: https://go4life.nia.nih.gov/). No recommendations for a specific exercise program will be made, except for walking 30 minutes daily or as tolerated. Each telephone session will cover 4 exercise tips and 4 healthy eating tips. The duration of the intervention is about 30 minutes. |
- Change in the Late-Life Function and Disability Instrument (LLFDI) Score [ Time Frame: At baseline and week 8 ]The LLFDI is a validated patient-reported outcome questionnaire that measures both functional limitations (inability to perform physical tasks - Activity Limitation Domain score, range: 0-100) and disability (inability to perform major life tasks and social roles - Participation Restriction Domain score, range: 0-100). For both scales, higher values indicate better function (lower limitation or lower disability). Two domain scores are analyzed separately.
- Change in the Short Physical Performance Battery (SPPB) Summary Score [ Time Frame: At baseline and week 8 ]The summary score is calculated based on chair stands, walking speed, and standing balance (range: 0-12). Higher scores indicate better physical performance.
- Change in the 2-Minute Walk Distance (Feet) [ Time Frame: At baseline and week 8 ]The 2-minute walk distance measures endurance. A longer distance indicates better endurance.
- Change in Dominant Hand Grip Strength (kg) [ Time Frame: At baseline and week 8 ]Dominant hand grip strength measures upper extremity strength.
- Number of Participants Who Experienced Adverse Events [ Time Frame: At week 8 ]Number of participants who experience any adverse events and serious adverse events
- Change in Mini-Mental State Examination (MMSE) Score [ Time Frame: At baseline and week 8 ]MMSE is an instrument that assesses general cognitive function (range: 0 to 30). Higher scores indicate better cognitive function.
- Change in New York Heart Association (NYHA) Functional Class [ Time Frame: At baseline and week 8 ]NYHA assesses the extent of physical activity limitation due to heart failure. It ranges from 1 (ordinary physical activity does not cause symptoms) to 4 (symptoms occur at rest).
- Change in the Self-Efficacy Scale for Exercise (SEE) [ Time Frame: At baseline and week 8 ]The SEE scale measures self-efficacy about exercise (range: 0-90). Higher values indicate higher self efficacy.
- Change in the Outcome Expectation Scale for Exercise (OEE) [ Time Frame: At baseline and week 8 ]The OEE scale measures outcome expectation about exercise (range: 9-45). Higher scores indicate higher expectation.
- Adherence to the Home-based Exercise Program [ Time Frame: At week 8 ]The proportion of days with completed daily task during the entire study period will be measured.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 65 Years and older (Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age ≥ 65 years
- Underwent transcatheter aortic valve replacement
- Lives within 20-mile radius of the recruiting site
- Plan to be discharged home
- Able to provide informed consent
Exclusion Criteria:
- Stroke or any other medical disease that precludes participation in the exercise program
- Severe cognitive impairment (Mini-Mental State Examination < 15)
- Current enrollment in another clinical trial
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02805309
| United States, Massachusetts | |
| Brigham and Women's Hospital | |
| Boston, Massachusetts, United States, 02120 | |
| Hebrew SeniorLife | |
| Boston, Massachusetts, United States, 02131 | |
| Beth Israel Deaconess Medical Center | |
| Boston, Massachusetts, United States, 02215 | |
| Principal Investigator: | Dae Hyun Kim, MD, MPH, ScD | Beth Israel Deaconess Medical Center |
Documents provided by Dae Hyun Kim, MD, MPH, ScD, Brigham and Women's Hospital:
| Responsible Party: | Dae Hyun Kim, MD, MPH, ScD, Associate Physician, Brigham and Women's Hospital |
| ClinicalTrials.gov Identifier: | NCT02805309 |
| Other Study ID Numbers: |
2017P000106 P30AG031679 ( U.S. NIH Grant/Contract ) P30AG048785 ( U.S. NIH Grant/Contract ) |
| First Posted: | June 20, 2016 Key Record Dates |
| Results First Posted: | July 21, 2021 |
| Last Update Posted: | July 21, 2021 |
| Last Verified: | June 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Transcatheter Aortic Valve Replacement Exercise Frailty Functional Outcomes Cognitive Behavioral Intervention |
|
Aortic Valve Stenosis Aortic Valve Disease Heart Valve Diseases |
Heart Diseases Cardiovascular Diseases Ventricular Outflow Obstruction |

